Drug Pipeline

Saroglitazar Magnesium 1 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07216235 Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary… Primary Biliary Cholangitis Not Yet Recruiting
NCT06427395 Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary… Primary Biliary Cholangitis Active, Not Recruiting
NCT07424677 Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant… Primary Biliary Cholangitis Not Yet Recruiting
Phase 1
NCT05045482 Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease Hepatic Impairment Recruiting
Sponsors Running Saroglitazar Magnesium 1 mg Trials
Get alerts when Saroglitazar Magnesium 1 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free